Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bone Biologics's enterprise value was -$3.40M on Nov 11, 2026, against -$3.36M a year earlier. Over the last 5 years it ranged from -$3.45M to $259.23M, with a median of $6.35M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.40M | – |
| 2025 | Dec 31, 2025 | -$3.45M | -141.7% |
| 2024 | Dec 31, 2024 | $8.26M | +33.9% |
| 2023 | Dec 29, 2023 | $6.17M | -18.5% |
| 2022 | Dec 30, 2022 | $7.57M | -97.1% |
| 2021 | Dec 31, 2021 | $259.23M | -81.4% |
| 2020 | Dec 31, 2020 | $1.39B | +86.3% |
| 2019 | Dec 31, 2019 | $747.44M | -43.5% |
| 2018 | Dec 31, 2018 | $1.32B | – |
See a number that looks wrong?